To say that Krystal Lashley went to great lengths to get the Novavax COVID-19 vaccine (NVX-CoV2373) would be a gross understatement. In April, Lashley traveled roughly 3700 miles from her home in Metuchen, New Jersey, to a pharmacy in Paris, France, for her first dose. She then flew to the […]
Read More
Lo que necesita saber Los CDC recomiendan que todas las personas mantengan al día su vacunación contra el COVID-19, incluidas todas las dosis del esquema principal y las dosis de refuerzo correspondientes a su grupo de edad: Las personas de 6 meses a 4 años deben recibir todas las dosis del esquema […]
Read More
This site provides an integrated, county view of key data for monitoring the COVID-19 pandemic in the United States. It allows for the exploration of standardized data across the country.§ The footnotes describe each data source and the methods used for calculating the metrics. For the most complete and up-to-date data […]
Read More
El Comité de Medicamentos de Uso Humano de la Agencia Europea del Medicamento, CHMP, ha recomendado autorizar una vacuna bivariante adaptada a las subvariantes BA.4 y BA.5, que contiene, además, la cepa ancestral del SARS-CoV-2. El preparado vacunal ha sido elaborado por Pfizer/BioNTech para personas de doce o más años, con […]
Read More
Anyone can get an infection, and almost any infection, including COVID-19, can lead to sepsis. In a typical year: At least 1.7 million adults in America develop sepsis. At least 350,000 adults who develop sepsis die during their hospitalization or are discharged to hospice. 1 in 3 people who dies in a hospital had sepsis […]
Read More
El Documento de consenso para el manejo de la esquistosomiasis en atención primaria tiene como objetivo dar recomendaciones claras al facultativo en la detección, seguimiento y tratamiento de dicha enfermedad.[1] En la elaboración de este texto han participado 5 sociedades científicas: Sociedad Española de Medicina de Familia y Comunitaria (SEMFyC), Sociedad Española de […]
Read More
COVID-19, caused by SARS-CoV-2, is characterised by a broad spectrum of symptom severity that requires varying amounts of care according to the different stages of the disease. Intervening at the onset of mild to moderate COVID-19 symptoms in the outpatient setting would provide the opportunity to prevent progression to a […]
Read More
The incubation period from infection to symptoms or a first positive COVID-19 test has decreased as the coronavirus has evolved, dropping from 5 days to 3.5 days, according to a new study published in JAMA Network Open. With the Alpha variant, the incubation period was about 5 days, which fell to 4.5 for […]
Read More
JYNNEOS vaccine is licensed as a series of two doses administered 28 days (4 weeks) apart. The standard regimen involves a subcutaneous (Subcut) route of administration with an injection volume of 0.5mL. The standard regimen is the FDA-approved dosing regimen. Since August 9, 2022, the standard regimen has been authorized for people […]
Read More
Maybe you’ve been there before. The body aches. The loss of smell and taste. The positive test. Maybe you thought you were done with COVID-19. Maybe you thought it was like chickenpox — if you’ve had it once, you’re immune forever, and you can put your worries away for good. […]
Read More